Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Difficult KOLs: How to overcome challenges, find success and gain access
Summary
In this episode, Andrea Johnson joins Tom Caravela to delve into effective strategies for Medical Science Liaisons. They explore the value of Key Opinion Leaders (KOLs), emphasizing the importance of pre-call planning and preparation. Andrea shares techniques for building strong connections with KOLs and utilizing internal resources effectively. The conversation covers networking tips, the significance of text relationships, and handling challenging interactions. They discuss overcoming negative experiences and the importance of respect in professional relationships. The episode concludes with key takeaways and a call to action for listeners.
My guest today, is Andrea Johnson, National Director, MSLs. Andrea discusses how to overcome challenges, find success and gain access to difficult KOLs
Andrea shares…
π Interesting stories about difficult KOLs
π Some effective strategies and best practices for turning around difficult KOLs
π Practical tips for KOL relationship building
π How important pre-call planning is as a practice
π What ideas or creative strategies she has seen work for gaining access with tough KOLs
Medical Science Liaisons, Key Opinion Leaders, pre-call planning, KOL relationship building, overcoming challenges
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary